Immune modulator drugs improves survival for people hospitalised with COVID-19 EP News Bureau Jun 3, 2022 NIH launched the ACTIV-1 immune modulators clinical trial to determine if certain drugs that help minimise the effects of an…
US FDA accepts Bristol Myers Squibb’s application for Orencia for priority review EP News Bureau Aug 24, 2021 If approved, Orencia would become the first therapy for the prevention of acute graft versus host disease (aGvHD)
